Related references
Note: Only part of the references are listed.Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19
Jacques Fantini et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)
Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection
Yuehai Pan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2021)
Targeting Lipid Rafts as a Strategy Against Coronavirus
Maurizio Sorice et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Rationale for the use of sphingosine analogues in COVID-19 patients
Deborah R. Tasat et al.
CLINICAL MEDICINE (2021)
Sphingosine is able to prevent and eliminate Staphylococcus epidermidis biofilm formation on different orthopedic implant materials in vitro
Sascha Beck et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
Qihui Wang et al.
CELL (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection
Jacques Fantini et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Sphingosine kills bacteria by binding to cardiolipin
Rabea Verhaegh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
Judith Lang et al.
NATURE COMMUNICATIONS (2020)
A Role of Sphingosine in the Intracellular Survival of Neisseria gonorrhoeae
Franziska Solger et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System?
Elisabetta Meacci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2
Michael J. Edwards et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
Kyle McEvoy et al.
JOURNAL OF FUNGI (2020)
Small-molecule ion channels increase host defences in cystic fibrosis airway epithelia
Katrina A. Muraglia et al.
NATURE (2019)
Sphingosine-coating of plastic surfaces prevents ventilator-associated pneumonia
Aaron P. Seitz et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2019)
Genetic deletion of Sphk2 confers protection against Pseudomonas aeruginosa mediated differential expression of genes related to virulent infection and inflammation in mouse lung
David L. Ebenezer et al.
BMC GENOMICS (2019)
Sphingosine 1-phosphate and inflammation
Hideru Obinata et al.
INTERNATIONAL IMMUNOLOGY (2019)
Sphingolipids and their metabolism in physiology and disease
Yusuf A. Hannun et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Sphingosine rescues aged mice from pulmonary pseudomonas infection
Teresa C. Rice et al.
JOURNAL OF SURGICAL RESEARCH (2017)
Sphingosine's role in epithelial host defense: A natural antimicrobial and novel therapeutic
Grace E. Martin et al.
BIOCHIMIE (2017)
β1-Integrin Accumulates in Cystic Fibrosis Luminal Airway Epithelial Membranes and Decreases Sphingosine, Promoting Bacterial Infections
Heike Grassme et al.
CELL HOST & MICROBE (2017)
Lack of Sphingosine Causes Susceptibility to Pulmonary Staphylococcus Aureus Infections in Cystic Fibrosis
Shaghayegh Tavakoli Tabazavareh et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2016)
Sphingosine-1-phosphate signaling: unraveling its role as a drug target against infectious diseases
Mohd Arish et al.
DRUG DISCOVERY TODAY (2016)
Sphingolipids as targets for treatment of fungal infections
Rodrigo Rollin-Pinheiro et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Frontline Science: Sphingosine rescues burn-injured mice from pulmonary Pseudomonas aeruginosa infection
Teresa C. Rice et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Principles of Virus Uncoating: Cues and the Snooker Ball
Yohei Yamauchi et al.
TRAFFIC (2016)
Persistence of HCV in Acutely-Infected Patients Depletes C24-Ceramide and Upregulates Sphingosine and Sphinganine Serum Levels
Georgios Grammatikos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response
Alexandra E. Paharik et al.
MICROBIOLOGY SPECTRUM (2016)
Autophagic flux and autophagosome morphogenesis require the participation of sphingolipids
Chiara Tommasino et al.
APOPTOSIS (2015)
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
Steven Y. C. Tong et al.
CLINICAL MICROBIOLOGY REVIEWS (2015)
Cell entry mechanisms of HSV: what we have learned in recent years
Alex M. Agelidis et al.
FUTURE VIROLOGY (2015)
Disseminated Gonococcal Infection Presenting as Bacteremia and Liver Abscesses in a Healthy Adult
Min Hye Lee et al.
INFECTION AND CHEMOTHERAPY (2015)
The Virome in Mammalian Physiology and Disease
Herbert W. Virgin
CELL (2014)
Update on Epidemiology of and Preventive Strategies for Invasive Fungal Infections in Cancer Patients
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2014)
Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa
Yael Pewzner-Jung et al.
EMBO MOLECULAR MEDICINE (2014)
Ventilator-associated pneumonia in the ICU
Atul Ashok Kalanuria et al.
CRITICAL CARE (2014)
Sphingoid Bases Are Taken Up by Escherichia coli and Staphylococcus aureus and Induce Ultrastructural Damage
C. L. Fischer et al.
SKIN PHARMACOLOGY AND PHYSIOLOGY (2013)
Antibacterial Activity of Sphingoid Bases and Fatty Acids against Gram-Positive and Gram-Negative Bacteria
Carol L. Fischer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Ebola virus entry requires the host-programmed recognition of an intracellular receptor
Emily Happy Miller et al.
EMBO JOURNAL (2012)
Membrane Disruption by Antimicrobial Fatty Acids Releases Low-Molecular-Weight Proteins from Staphylococcus aureus
Joshua B. Parsons et al.
JOURNAL OF BACTERIOLOGY (2012)
The dependence of viral RNA replication on co-opted host factors
Peter D. Nagy et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Herpes simplex virus infects most cell types in vitro: clues to its success
Ghadah A. Karasneh et al.
VIROLOGY JOURNAL (2011)
DC-SIGN Mediated Sphingomyelinase-Activation and Ceramide Generation Is Essential for Enhancement of Viral Uptake in Dendritic Cells
Elita Avota et al.
PLOS PATHOGENS (2011)
Acid Sphingomyelinase Inhibitors Normalize Pulmonary Ceramide and Inflammation in Cystic Fibrosis
Katrin Anne Becker et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Sphingosine 1-phosphate and cancer
Nigel J. Pyne et al.
NATURE REVIEWS CANCER (2010)
Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease
Timothy F. Murphy
CURRENT OPINION IN PULMONARY MEDICINE (2009)
Bioactive sphingolipids: metabolism and function
Nana Bartke et al.
JOURNAL OF LIPID RESEARCH (2009)
Chronic Pseudomonas aeruginosa Infection in Chronic Obstructive Pulmonary Disease
Laura Martinez-Solano et al.
CLINICAL INFECTIOUS DISEASES (2008)
Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis
Volker Teichgraeber et al.
NATURE MEDICINE (2008)
Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis
Ching G. Ng et al.
JOURNAL OF VIROLOGY (2006)
New insights into pulmonary inflammation in cystic fibrosis
S. Rao et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2006)
Host sphingolipid biosynthesis as a target for hepatitis C virus therapy
H Sakamoto et al.
NATURE CHEMICAL BIOLOGY (2005)
Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms
H Grassmé et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Current concepts - Treatment of infections associated with surgical implants
RO Darouiche
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The complex life of simple sphingolipids
AH Futerman et al.
EMBO REPORTS (2004)
Aminoacylase 1 is a sphingosine kinase 1-interacting protein
M Maceyka et al.
FEBS LETTERS (2004)
Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases
A Billich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Yeast sphingolipids: metabolism and biology
LA Obeid et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2002)
Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth
SB Levery et al.
FEBS LETTERS (2002)
Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus
J Arikawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2002)
Ventilator-associated pneumonia
J Chastre et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Sphingolipids in mammalian cell signalling
J Ohanian et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2001)
Antibiotic resistance of bacteria in biofilms
PS Stewart et al.
LANCET (2001)
Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth
ML Rodrigues et al.
INFECTION AND IMMUNITY (2000)
Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species
WY Zhong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
